Medidata has launched the Medidata Site Insights Program, aimed at expediting the delivery of life-changing therapy to trial ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

The first-of-its-kind facility in India has received an investment of $75 million from the company to build it vertically ...